Hawthorne, NY, April 11, 2003 – Taro Pharmaceutical Industries Ltd. (Nasdaq/NMS: TARO) intends to report financial results for the first quarter of 2003 prior to the Nasdaq market opening on Wednesday, April 16, 2003. The Company will conduct a conference call to discuss the results on the same day at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time).
The conference call will be hosted by Barrie Levitt, M.D., Chairman of the Company, who will review the quarter along with Kevin Connelly, Chief Financial Officer, and Daniel Saks, Vice President, Corporate Affairs. The call will be available live via the Internet by accessing www.taro.com.
Online and telephone replays of the call will be available from approximately 11:00 a.m. on April 16th through April 23, 2003. The online replay can be accessed at www.taro.com. The telephone replay can be heard by dialing 1-800-428-6051 (domestic U.S.) or +973-709-2089 (international) and entering the passcode 289566 when prompted.
Taro is a multinational, science-based pharmaceutical company dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products.
For more information on Taro, please visit www.taro.com.
# # #